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Abstract
Human mismatch repair proteins MSH2-MSH6 play an essential role in maintaining genetic stability and preventing disease.
While protein functions have been extensively studied, the substantial amino-terminal region (NTR*) of MSH6 that is unique
to eukaryotic proteins, has mostly evaded functional characterization. We demonstrate that a cluster of three nuclear
localization signals (NLS) in the NTR direct nuclear import. Individual NLSs are capable of partially directing cytoplasmic
protein into the nucleus; however only cooperative effects between all three NLSs efficiently transport MSH6 into the
nucleus. In striking contrast to yeast and previous assumptions on required heterodimerization, human MSH6 does not
determine localization of its heterodimeric partner, MSH2. A cancer-derived mutation localized between two of the three
NLS significantly decreases nuclear localization of MSH6, suggesting altered protein localization can contribute to
carcinogenesis. These results clarify the pending speculations on the functional role of the NTR in human MSH6 and identify
a novel, cooperative nuclear localization signal.
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Introduction
The mismatch repair system (MMR) is one of the key DNA
repair systems, ubiquitously found in most organisms investigated
to-date. It recognizes and repairs errors occurring during DNA
replication, increasing the fidelity of this essential cellular process
[1,2]. Defects in these proteins dramatically increase genetic
instability, providing the underlying cause for all ‘‘hallmarks of
cancer’’ [3].
Best studied in Escherichia coli, a homodimer of MutS proteins
recognizes mismatched DNA and initiates repair. In mammalian
cells, MMR shows higher complexity. The homodimeric MutS is
replaced by two heterodimeric complexes consisting of MSH2-
MSH6 and MSH2-MSH3 with different, but overlapping
substrate specificity [4,5,6]. Binding of these heterodimeric
complexes to mismatched DNA initiates subsequent, consecutive
steps that involve ATP binding and hydrolysis to recruit
downstream proteins and lead to the excision of the mismatched
DNA and resynthesis.
Additional complexity is added to the mammalian proteins by
the addition of an extra 300–400 amino acid stretch to the N-
terminus of MSH6 and MSH3 proteins, not found in their
prokaryotic counterparts or in MSH2 (Figure 1A). This N-
terminal region (NTR) of the protein has attracted significant
attention in the scientific world, primarily due to the fact that
despite its size, few signature motifs are identifiable. The most
extensively studied function for this NTR resides in its far N-
terminus which contains a functional PCNA binding motif
(Figure 1A, ‘‘PIP’’) [7,8] that tethers the MMR machinery to
the replication fork machinery [9]. Subsequently, small-angle X-
ray scattering described the NTR of yeast Msh6 as an
unstructured tether to PCNA, providing a flexible linker between
the protein and PCNA [10]. In human cells, such an unstructured
tether could not be identified by the same technique, suggesting a
difference between yeast and human protein [11]. The only other
functional consequence of mutations within the NTR identified
non-specific DNA binding that involves amino acids 228–299 of
yeast Msh6 [8] and a PWWP domain in the human MSH6 [12]
(Figure 1A). Despite these earlier reports, the function of
remaining parts of the human MSH6-NTR remains enigmatic.
Much effort has been spent on describing the functions of MMR
proteins, culminating in detailed insight into their mechanism, yet
how these proteins are localized in cells and the determinants for
this localization are not well defined. Only recently has one
publication attempted to address the nuclear and cytoplasmic
localization for the yeast MSH proteins [13]. This study found that
yeast Msh6 was excluded from the nucleus in the absence of Msh2,
and that, while Msh2 could localize to the nucleus independent of
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partner protein [13]. This suggests that transport and stability of
yeast Msh2 and Msh6 are synergistically enhanced by hetero-
dimerization; a phenomenon that has been observed for nuclear
import of human MLH1 and PMS2 as well [13,14,15].
Though yeast model systems are frequently used as an
equivalent for the human system, recent findings suggest
discrepancies between lower and higher eukaryotic systems.
Whether above findings therefore hold true for human MSH2
and MSH6 remains to be determined; the only information on
subcellular localization for the human proteins was indirectly
found after exposure to DNA damaging agents. In these studies,
MSH2 and MSH6 were found to re-localize to sites of damage
after exogenous insult [16,17,18,19]. Deletion of the NTR from
MSH6 was also found to affect accumulation of MSH6 to sites of
DNA damage independent of PCNA binding [19].
Classical nuclear localization signals have been divided into
monopartite, containing a single cluster of basic amino acid
residues, and bipartite sequences, containing two clusters of basic
amino acid residues separated by 10–12 amino acids. Loose
consensus sequences have been established for both monopartite,
K(K/R)X(K/R), and bipartite signals, (K/R)(K/R)X10–12(K/R)3–5,
where (K/R)3–5 represents at least three either lysine or arginine out
of the five consecutive amino acids [20]. Examination of the human
MSH2 and MSH6 amino acid sequences identified no predicted
NLSs in MSH2 [15,21,22] and four predicted NLSs in MSH6, all
residing in the NTR region [22].
Utilizing confocal microscopy and site-directed mutagenesis, we
demonstrate that three functional monopartite NLSs are located in
a region of unknown function in the human MSH6 NTR.
Furthermore, we show that, while these individual NLSs have
varying degrees of activity, they show unusual cooperativity in
localizing MSH6 to the nucleus. Absence of this NTR region or
deletions of individual NLSs affects nuclear transport of MSH6,
yet does not alter the localization of its heterodimeric partner,
MSH2, suggesting important differences between the human
MMR proteins and the lower eukaryotic counterparts. A cancer-
derived point mutation in MSH6 (S285I), within the general
region of the NLS alters the nuclear localization of the protein,
suggesting that not only protein function, but cellular distribution
may contribute to carcinogenesis. Given that correct subcellular
localization is a prerequisite for all subsequent cellular functions,
the identification of unique, cooperative NLSs that provides a new
role for an uncharacterized region of human MSH6 is of high
significance.
Results
Identification of human MSH6 nuclear localization signals
Maintenance of genomic fidelity requires MSH6, the protein
subunit of the MSH2/MSH6 heterodimer responsible for correct
mismatch recognition, to correctly localize into the nuclear
compartment. Examination of the spatial distribution of endogenous
MSH6 in HEK 293 and DLD-1 + chr.2 (chromosome 2
complemented colorectal cancer cell line DLD, which is deficient
in hmsh6 [23]) cells reveals that MSH6 is primarily nuclear (Figure
S2A, B). This distinct nuclear compartmentalization within the cell
is recapitulated by both fluorescently tagged proteins (Figure 2A)
and FLAG-tagged constructs (Figure S3). Given that no significant
difference in compartmentalization was observed between the
fluorescently-tagged proteins and constructs with the shorter
FLAG tag (Figure S3), only GFP-tagged constructs will be
reported. It is noteworthy that endogenous or tagged MSH2 is
distributed between the nucleus and cytoplasm; its localization is
Figure 1. Identification of three nuclear localization sequences in an uncharacterized region of the N-terminal region of MSH6 that
are only conserved in higher eukaryotes. (A) Schematic drawing of human MSH6 detailing its N-terminal region. PCNA interaction motif (PIP) is
shown in blue, PWWP domain in purple, and predicted non-specific DNA interaction domain is shown in green. Identified potential nuclear
localization sequences are highlighted in blue, red and purple (NLS1, NLS2, and NLS3). Cancer mutation S285I is indicated in bold. (B) Clustal
alignment of MSH6 N-terminal regions from different eukaryotic species demonstrating location of the NLSs. Yeast Msh6 contains no comparable
region to those found in higher eukaryotes, as shown. The higher eukaryotic species contain highly similar and closely spaced NLSs to those found in
human MSH6.
doi:10.1371/journal.pone.0017907.g001
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This finding and the separate nuclear import mechanism observed
in MSH2 will be discussed in more detail elsewhere (manuscript
submitted and in preparation).
GFP-MSH6 is predominantly found in the nuclear compart-
ment of the cells (Figure 2A and 3A). Sequential truncations of the
NTR of MSH6 reveal a distinct alteration in the localization
pattern between residue 211 and 399 of the NTR. As shown in
Figure 2B–C, deletion of the first 100 amino acids and 210 amino
acids of the NTR, respectively, result in no alteration in nuclear
localization; however, deletion of the first 399 amino acids results
in complete nuclear exclusion of MSH6 (Figure 2D). These data
demonstrate that amino acids 211–399 of the NTR play a role in
nuclear localization, and are independent of the PCNA binding
domain, which is found in the first 10 amino acids and the PWWP
domain contained within the first 210 amino acids (Figure 1A). To
determine that the mutant does not affect any essential function of
the protein that could be important for its cellular distribution, we
determined the ability of the wild type and mutant GFP-tagged
proteins to interact with MSH2. Results showed that wild type and
mutant MSH6 equally pulled out MSH2 in the IP experiment that
was performed with a GFP antibody (Figure S1).
To identify the specific localization signals, we screened the
amino acid sequence of MSH6 for putative nuclear localization
signals. Using both PSORTII (http://psort.ims.u-tokyo.ac.jp/
form2.html) and NLSmapper (http://nls-mapper.iab.keio.ac.jp/
cgi-bin/NLS_Mapper_form.cgi [22]), four putative NLSs were
identified for MSH6: three monopartite, NLS1
246KKRR
249,
NLS2
298RKRKR
302, and NLS3
311KRK
313, and one potential
bipartite sequence that combines NLS2 and 3
298RKRKRMVT-
GNGSLKRK
313 (Figure 1A,B). This bipartite varies significantly
from experimentally determined bipartite NLS sequences, ap-
pearing inverted in sequence [20,22,24] and is only conserved
among MSH6 proteins of higher eukaryotes (Figure 1B).
Deletion of the NTR, which contains the three predicted NLSs,
results in complete nuclear exclusion of MSH6 (Figure 2D);
therefore, to determine the functionality of each putative NLS
sequence, we deleted each sequence individually (Figure 3B–F).
The GFP-MSH6 NLS mutants were transiently transfected into
msh6-deficient DLD-1 cells (which contain endogenous MSH2),
which have been described extensively [25], and their subcellular
localization examined by confocal microscopy (Figure 3B–F).
Transient transfection results in variable levels of protein
expression, which cannot be accurately quantified. To deal with
this problem, we examined the individual intensity of cells
transiently transfected with GFP-MSH6 and created threshold
ranges that grouped cells with similar intensity and produced the
correct localization pattern observed for endogenous wild type
MSH6. Three threshold ranges were identified: low, medium and
high (for settings see Material and Methods). The low and medium
thresholds best recapitulate the compartment-specific localization
of endogenous MSH6, while the high threshold contained cells
with large aggregates of GFP, which created intensely saturated
bright spots. Cells at the ‘‘high level’’ were therefore omitted from
analysis. The medium threshold was used to obtain high resolution
images for these studies since the fluorescence signal showed less
photobleaching than the low threshold settings. For each cell, the
fluorescence intensities of MSH6 in the nucleus and the cytoplasm
were measured and the ratio of nuclear/cytoplasmic (N/C)
fluorescence was calculated (Materials and Methods).
As illustrated in Figure 3B–H, deletion of the individual
putative NLSs resulted in a distinct pattern of localization.
Deletion of monopartite NLS2 (Figure 3C) and bipartite NLS2/3
(Figure 3E) resulted in nuclear exclusion of MSH6 (N/
C=0.3560.02 and N/C=0.1960.01, respectively, Figure 3C,
E, H, Table 1). Deletion of monopartite NLS1 also dramatically
diminished the nuclear import (N/C=0.5360.25, Figure 3B, H,
Table 1); however, a mixed localization pattern was observed for
this mutant with ,40% of the cells showing complete nuclear
exclusion and the remaining cells showing a varying degree of
nuclear localization (data not shown). Deletion of NLS3 results in
impairment of nuclear import to a lesser degree than the other
NLSs, (N/C=2.8160.02, p=0.0108, Figure 3D, H, Table 1).
The Dmsh6 cells used for transfections in these experiments
contain endogenous MSH2, making it unlikely that the lack of
protein partner has an effect on the cellular distribution; however,
to verify this, we co-transfected wild type dsRed-MSH2 with
GFP-MSH6 D1–399. As seen in Figure 3G, the localization of
dsRed-MSH2 is unaltered and present in the nucleus and
cytoplasm.
Figure 2. Identification of amino acid stretch in NTR of MSH6 that directs nuclear localization using N-terminal deletion mutants of
human GFP-tagged MSH6 in Dmsh6 cells. Shown are widefield fluorescent images (green) and its overlay with the DIC image to indicate cellular
outline. Hoechst staining (blue) indicates the location of the nucleus. All scale bars are 10 mm. (A) GFP-MSH6, full length protein; (B) GFP-MSH6
D1–100; (C) GFP-MSH6 D1–210; (D) GFP-MSH6D1–399. A clearalteration in nuclearlocalizationis observed upon the truncationof amino acids 211–399.
doi:10.1371/journal.pone.0017907.g002
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To determine whether the identified NLSs are sufficient to
mediate nuclear import, we expressed GFP-tagged cytosolic
chicken muscle pyruvate kinase (CMPK) [26], (PK-GFP). This
protein construct lacks an NLS and shows nuclear exclusion of the
fusion protein (N/C=0.2260.02) (Figure 4A, Table 1). Given the
proximity of the NLSs in the NTR, amino acids 241–315 were
fused to the N-terminus of the PK-GFP reporter plasmid (NLS1/
2/3 PK-GFP, Figure 4B). Individual NLSs and pair-wise
combinations were created by site-directed mutagenesis, and the
localization of these proteins was quantified as described above.
NLS1/2/3 PK-GFP showed import levels similar to those
observed for wild type GFP-MSH6 (Compare N/C=3.9560.28
to N/C=4.5460.5, Figs. 3A and 4B and G, Table 1). However,
examination of the individual putative NLSs revealed they
directed the cytosolic PK-GFP fusion protein into the nucleus to
a lesser degree. NLS1, NLS2, and NLS2/3 attained similar levels
of localization (N/C of 1.460.16, 1.4960.1, 1.5260.14, respec-
tively) (Figure 4C, image not shown, E, G, Table 1,), while, NLS3
shows no significant accumulation over the negative control
(Figure 4D, G, Table 1). Paired combinations of NLS1 with NLS2
(N/C=2.3560.15, image not shown, Figure 4G, Table 1) or
NLS3 (N/C=2.7960.21, Figure 4F, G), showed significant
improvement in nuclear accumulation (p,0.0001), despite the
49 or 62 intervening amino acid between these sites, though still
failed to achieve comparable levels to NLS1/2/3 PK-GFP. As a
control, a fusion containing only the intervening residues between
all three NLSs showed no significant nuclear accumulation
(N/C=0.3660.06, image not shown, Figure 4G, Table 1),
validating import is directed by the identified NLSs.
Kinetic modeling suggests cooperativity between NLSs
To validate cooperation between the identified NLSs, we used
the experimental data to create a kinetic model of the import of
cytoplasmic protein into the nucleus. The reaction scheme used is
a simple implicit model of complex formation and transport (see
Figure 5 for the full model, presented diagrammatically with 12
species and 14 reactions). This model addresses the question of
whether or not the changes in nuclear transport can be explained
by the existence of multiple, independent NLSs, assuming
transferability between mutant experiments, or on the requirement
for cooperativity.
The key parameters in the model are the relative stabilities of
each complex in the nucleus relative to their stability in the
cytoplasm. Based on these parameters, the model can estimate
relative changes in free energies by determining how the relative
stabilities change as the models becomes increasingly complex
(Table 2). The first model is a single NLS model (Figure 5,
MSH6_b1, _b2 or _b3, referring to MSH6 bound to an import
protein binding to NLS1 or NLS2 or NLS3 separately); kinetic
parameters can be scanned to determine those that are most
consistent with the experimental data. The next model contains
two NLSs. In a non-cooperative model, the binding to both NLS 2
and NLS 3 would be the same as the sum of the binding the
Figure 3. Deletion of predicted NLS from human GFP-tagged MSH6 in Dmsh6 cells. Shown are the fluorescent view (green) and its overlay
with the DIC image to indicate cellular outline. All scale bars are 10 mm. (A) GFP-MSH6, (B) GFP-MSH6 DNLS1, (C) GFP-MSH6 DNLS2, (D) GFP-MSH6
DNLS3, (E) GFP-MSH6 DNLS2/3, (F) GFP-MSH6 DNLS1/2/3. (G) Co-transfection with dsRed-MSH2 and GFP-MSH6 D1–399, (H) Nuclear to cytoplasmic
ratios quantified for the corresponding NLS deletion mutants shown.
doi:10.1371/journal.pone.0017907.g003
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required when both NLS 2/3 are bound; this is a thermodynamic
signature of cooperativity. The same observation is made for NLS
1/2, NLS 1/3 and for the binding of all three NLSs.
Heterodimerization is not a prerequisite for nuclear
import in undamaged cells
Our initial data suggested localization of individual proteins
independent of their heterodimeric partner. To determine if the
localization of human MSH6 indeed did not direct the localization
of MSH2, as reported for the yeast orthologs, we utilized
immunofluorescence to visualize the localization of endogenous
MSH2 in msh6 deficient cells. The genetic deficiency would result
in mislocalization of MSH2, if MSH6 was required for its nuclear
import. In contrast to the yeast proteins, lack of MSH6 did not
affect or alter the cellular distribution of MSH2 (Figure 6A), which
is also evident by co-transfection of the deficient MSH6 with wild
type MSH2 (Figure 3G). When MSH6 expression is restored by
transient expression of our GFP fusions, no alteration in MSH2
cellular distribution is observed (Figure 6B,C).
These data are in striking difference to previous results in yeast
or after exposure to DNA damaging agents, and suggest that the
presence of human MSH6 is not a pre-requisite for nuclear import
of MSH2 in undamaged cells. To rule out that endogenous MSH3
takes over import of MSH2, we repeated experiments in cells
lacking both endogenous MSH3 and MSH6 (Figure S5). The
localization of endogenous MSH2 in cells lacking both MSH3 and
MSH6 was unaltered and remained distributed between the
nucleus and cytoplasm (Figure S5A). Expression of GFP-MSH6
DNLS2/3 did not alter the localization of endogenous MSH2 in
these cells (Figure S5B).
Cancer-derived point mutation in MSH6 alters subcellular
localization
A numberof cancer-derived pointmutationshavebeenidentified
near or within the NTR region (a.a. 241–315), though none of these
mutations directly affect the MSH6 NLS identified herein. To
determine if these point mutations created defects in the subcellular
localizationofMSH6,whichwouldbe missedbyin vitrobiochemical
analyses, we introduced several of these point mutations into the
GFP-MSH6 fusion and quantified the nuclear to cytoplasmic ratios.
While most point mutations showed no significant alteration in
cellular localization, one, S285I (Figure 1), showed a significant
defect in nuclear localization (p,0.0001; Table 1). This mutation
was previously characterized by a low microsatellite instability
phenotype [27], and a lack of functional defects, such as defective
heterodimerization or ATP hydrolysis [28]. Its altered cellular
localization is likely due to changes in the overall conformation of
the NTR regions rather than a direct effect on the nuclear
localization sequences; but it demonstrate that a single point
mutation can affect cellular localization and may even contribute to
carcinogenesis, without affecting protein function.
Discussion
These studies for the first time identified a novel mechanism for
nuclear import of human MSH6 that differs from that identified in
lower eukaryotic cells in that it is independent of its heterodimeric
partner.
Correct localization of MMR proteins into the nucleus is critical
to their proper function. Two classes of NLSs have previously been
identified, monopartite and bipartite, and loose consensus
sequences established for both. Examination of human MSH6
revealed three putative monopartite NLSs (NLS1, 2 and 3) and
one potential bipartite NLS, a combination of two identified
monopartite sequences (NLS2/3), in the NTR of MSH6, a
substantial N-terminal protein region that has evaded functional
characterization to-date. Inspection of the NTR region of other
higher eukaryotes shows similar and closely spaced NLSs
(Figure 1B), suggesting that cooperative NLSs may be utilized by
other higher eukaryotes to localize MSH6 into the nuclear
compartment. In contrast, the yeast Msh6 NTR does not contain a
similar region of clustered NLSs, indicating evolutionary separa-
tion between lower and higher eukaryotes.
The monopartite NLS1 and NLS2 are high scoring NLSs in
agreement with experimentally determined localization sequences,
while NLS3 is a low scoring, non-classical NLS [22]. The general
Table 1. Nuclear to Cytoplasmic Ratios (N/C) for GFP-MSH6 NLS deletions and NLS PK-GFP fusions.
GFP-MSH6 NLS mutants N/C Ratio ± SEM NLS PK-GFP fusions N/C Ratio ± SEM
Endogenous MSH6 (DLD1 + chr. 2) 9.0360.39
GFPfree 1.0060.06
GFP-MSH6 4.5460.5 PK-GFP 0.2060.02
GFP-MSH6 DNLS1 0.536 .25 No NLS PK-GFP 0.3660.06
GFP-MSH6 DNLS2 0.3560.02 NLS1 PK-GFP 1.4060.16
GFP-MSH6 DNLS3 2.8160.48 NLS2 PK-GFP 1.4960.1
GFP-MSH6 DNLS 1/2 0.1560.01 NLS3 PK-GFP 0.6160.05
GFP-MSH6 DNLS 2/3 0.1960.01 NLS1/2 PK-GFP 2.3560.15
GFP-MSH6 DNLS 1/2/3 0.1660.01 NLS1/3 PK-GFP 2.7960.21
GFP-MSH6 D1-399 0.160.01 NLS2/3 PK-GFP 1.5260.14
GFP-MSH6 S227I 3.636.45 NLS1/2/3 PK-GFP 3.9560.28
GFP-MSH6 S285I 1.786.26
GFP-MSH6 K295R 4.2260.7
GFP-MSH6 S315F 3.9560.46
Shown are standard errors for the indicated number of quantified cells.
Forty to sixty cells were quantified for each construct.
doi:10.1371/journal.pone.0017907.t001
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experimentally verified to promote nuclear import [29,30]. The
predicted bipartite sequence containing NLS2/3 is also a high
scoring NLS predicted to have significant levels of nuclear import;
however the consensus sequence appears inverted from experi-
mentally verified bipartite sequences [22]. Experimental validation
of these putative NLSs showed dramatic decreases in nuclear
transport when NLS1, NLS2, NLS 2/3, or NLS 1/2/3 were
deleted (Figure 3G), while NLS3 only produced a slight defect in
nuclear import when deleted (Figure 3G).
To confirm that these putative NLSs are sufficient to mediate
nuclear import, NTR region 241–315 was fused to a cytoplasmic
pyruvate kinase-GFP fusion and the individual NLSs, as well as
combinations of individual NLSs were examined. Nuclear
accumulation was observed for NLS1, NLS2, and NLS2/3
(Figure 4G), and weak accumulation for NLS3 alone (Figure 4G),
consistent with the predictions for the consensus matching of
these individual predicted NLSs [22]. However, the ability of
NLS2 alone to direct nuclear import to a similar degree as NLS2
and 3 together is inconsistent with NLS2 and 3 representing a
true bipartite sequence, as described for other proteins [24,31].
Bipartite nuclear localization signals are interdependent basic
domains, where the large monopartite-like domain is insufficient
to direct nuclear import of a cytoplasmic protein in the absence
of its partner domain [20,24]. Our data suggest that NLS2 and
NLS3 together do not form a bipartite nuclear localization
signal.
The individual NLSs were not capable of directing nuclear
protein import to the same degree as the combinations of two or
all three of the NLSs or to the same degree as wild type MSH6
(Figure 3H and 4G). Since levels of NLS activity vary dependent
on the sequences flanking the NLS [22], the proximity of the
predicted NLSs in the NTR made a cooperative effect between the
individual NLSs an intriguing possibility. Cooperative nuclear
Figure 4. Predicted NLSs are validated by their ability to import a cytoplasmic protein, pyruvate kinase, into the nucleus in Dmsh6
cells. (A) Pyruvate kinase-GFP fusion (PK-GFP); (B) NLS1 PK-GFP; (C) NLS3 PK-GFP; (D) NLS2/3 PK-GFP; (E) NLS 1/3 PK-GFP; (F) (MSH6 NLS1, 2&3)-PK-GFP.
(G) Nuclear to cytoplasmic ratios quantified for NLS pyruvate kinase fusions. The no NLS fusion contains only the intervening amino acids between
the predicted nuclear localization sequences to validate that this flanking sequence does not accomplish nuclear import in the absence of the
predicted NLS.
doi:10.1371/journal.pone.0017907.g004
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number of proteins, whether it be between different NLSs
sequences [32,33,34,35] or between NLSs and other protein
domains [36,37,38]. Since amino acids 241–315, containing all
three NLSs, significantly increases nuclear import over the effects
of the individual or pair-wise NLSs (Figure 4G), cooperation
between the sequences was considered. While the cooperative
effect of other proteins has been previously described, the
underlying mechanism by which these protein domains cooperate
is unknown.
To support our proposed cooperativity, we utilized kinetic
modeling. This method used the current experimental data to
model the full kinetic process of nuclear import and to estimate
missing parameters, such as the stability of the various NLS/
MSH6 complexes (Figure 5 and description therein). The kinetic
model supports cooperativity between the three individual
monopartite NLSs to efficiently translocate MSH6 into the
nuclear compartment.
The cooperative action of the tripartite NLS ensures that
human MSH6 is efficiently localized into the nucleus. While NLS1
and NLS2 appear to be the more dominant regions, NLS3
significantly enhances the efficacy of nuclear import by NLS1
alone or in combination with NLS2. These hierarchical NLSs
suggest the evolution of redundant, though less effective, delivery
systems for ensuring human MSH6 is localized into the nuclear
compartment that are distinct from lower eukaryotic systems.
Figure 5. The full kinetic model for import of MSH6 into the nucleus with 12 species and 14 reactions, is shown diagrammatically.
Each green ball is a molecular species or complex and each yellow oval is a reaction. The arrows into a yellow oval indicate those species are reactants
and errors out indicate the species are products. The different species and reaction types are organized spatially for clarity. Each of the four base
species, MSH6, and the binders to NLS1, NLS2, and NLS3 (bNLS1, bNLS2, bNLS3, respectively, are shown at the bottom as green circles as species that
are reactants for the formation reactions to which they are linked by inward arrows. The formation reactions that lead to complex formation are
shown in yellow in the middle, with the complexes formed shown at top as green circles; the complexes formed are linked to the correct formation
reactions by outward arrows. The complexes are named appropriately, so that for example, MSH6_b1 is the complex of MSH6 with the binder to
NLS1 and is connected via a yellow reaction oval to bNLS1 (the binder to NLS1) and MSH6 in the cytoplasm. The disintegration reactions that
implicitly model transport into the nucleus through complex disintegration are shown at top right in yellow, where they connect the appropriate
complex to the correct molecular species, leading to MSH6 in the nucleus. For example, MSH6_b1 is connected to MSH6 in the nucleus and bNLS1
(the binder to NLS1) via a disintegration reaction.
doi:10.1371/journal.pone.0017907.g005
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has no discernable effect on its heterodimeric partner, MSH2;
suggesting that MSH6 does not direct the localization of MSH2
(Figure 3G, 6). Localization of yeast proteins to the nuclear
compartment was found to be dependent on a reciprocal
regulation between Msh2 and Msh6 [13]. Yeast Msh2 contains
the necessary NLSs to direct itself independently to the nucleus;
however, the proteins levels of Msh2 were found to be diminished
in the absence of Msh6 [13]. Yeast Msh6 contains no putative
NLSs and is dependent on Msh2 for transport into the nucleus
[13]. Taken together, these results suggested that heterodimer
formation was required to efficiently localize the yeast Msh2 and
Msh6 into the nucleus and stabilize the monomeric proteins [13].
In striking contrast, human MSH2 contains no putative NLSs,
while MSH6 contains three cooperative NLSs, and thereby differs
from the yeast proteins. Despite the lack of NLSs, the absence of
human MSH6 does not abrogate localization of human MSH2
into the nucleus, nor does it diminish the protein levels of MSH2
(Figure S4). This indicates that MSH2 and MSH6 can localize
independently into the nucleus and that heterodimerization of
MSH2 and MSH6 is not a pre-requisite for the nuclear import of
the human proteins, in significant contrast to the yeast proteins.
Previous studies with human MSH2 and MSH6 suggested that
heterodimerization was a pre-requisite for nuclear import in the
presence of DNA damage [16,17]. Protein levels of MSH2 and
MSH6 were found to increase in the nucleus after DNA damage,
and nuclear transport of MSH2 was abrogated in MSH6 deficient
DLD-1 cells [16]. However, as shown in Figure 6, human MSH2
clearly localizes into the nuclear compartment independent of
human MSH6 in DLD-1 cells. Further, a recent study examined
the accumulation of human MMR proteins at laser-irradiated sites
and found that MSH6 accumulates at laser-irradiated sites in the
absence of MSH2 [19], suggesting human MSH2/6 heterodimer
formation is not required in the response to DNA damage. This
does not eliminate the possibility that MSH2 heterodimerizes with
any of its numerous other binding partners to accomplish nuclear
import, but does demonstrate that MSH2 and MSH6 achieve
nuclear localization independently and opens new avenues of
investigation into their independent regulation. To determine if
heterodimerization with MSH3, its alternate partner, affects
cellular localization of MSH2, we performed experiments in cells
that are deficient in both MSH3 and MSH6. Our data
demonstrate that the absence of MSH3 does not alter the
localization of MSH2 (Figure S5).
Mutations in human MSH6 are present in 12% of patients with
hereditary non-polyposis colorectal cancer [39]. Interestingly, 26
out of the 91 point mutations identified in MSH6 are located to
the NTR [39]. Mutations in MSH6 are associated with later age
onset than mutations in MSH2, and mutations are found more
often in endometrial cancer [40,41]. Recently a link between
mutations in MSH6 and childhood leukemia/lymphoma was
identified [42]. While a majority of MSH6 mutations are
truncations or deletions, about 30% of the MSH6 variants
reported are single amino acid substitutions [39]. A number of
studies have attempted to determine the biochemical defects of
these mutations in MSH6 [28,43]; however, the functional
consequences in whole cells are largely unknown.
The fact that defects in MMR proteins may alter the subcellular
localization without directly affecting protein function has been
largely ignored up to this point. A number of cancer-derived
mutations in MSH2 and MLH1 have been identified that alter
subcellular localization [21,44,45]. In the region identified to be
critical for nuclear localization of MSH6, we identified a single
point mutation, S285I, which significantly alters the subcellular
localization of MSH6. This mutation is associated with a low
microsatellite instability phenotype [27]; however, in vitro analysis
of this protein found no defects in its ability to heterodimerize with
MSH2 or hydrolyze ATP [28], despite its association with cancer.
Though this mutation does not reside directly in any of the
identified NLS, it has previously been shown that levels of NLS
activity are dependent on the sequences flanking the NLS [22].
The location of this mutation in the region flanking the two
dominant nuclear localization sequences, NLS1 and 2, makes it
probable that this cancer mutation disrupts some aspect of the
cooperation between NLSs, reducing the nuclear accumulation to
levels consistent with a single NLS. Alternatively, the mutation can
simply cause unfavorable structural changes in the region. These
results simply demonstrate that a single point mutation in the
vicinity of the NLS can affect cellular localization of proteins. This
is the first example of an MSH6 cancer mutation to show
Table 2. Cooperativity estimates from kinetic model.
NLS Cooperativity (Kcal/mol)
1/2 2.64
1/3 2.94
2/3 1.71
1/2/3 2.58
The cooperativity estimates are obtained by converting rate constants into free
energies and then subtracting from the free energy of binding of the pairs the
sum of the individual free energies. For the triplet, the cooperativity is
estimated by subtracting a free energy for a pair and the remaining single free
energy, and using the minimum of the three values found.
doi:10.1371/journal.pone.0017907.t002
Figure 6. A deficiency in MSH6 does not alter the localization of MSH2. Shown is the localization of endogenous MSH2 in Dmsh6 cells and
in Dmsh6 cell transfected with GFP-MSH6. Scale bars are 10 mm. (A) Alexa546 MSH2, (B) Alexa546 MSH2 and GFP-MSH6, (C) Alexa546 MSH2 and
GFP-MSH6 DNLS 1/2/3.
doi:10.1371/journal.pone.0017907.g006
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unexplored source of promoting carcinogenesis. These data
caution on the importance of whole cell behavior when studying
cancer-associated mutations and their effects.
Materials and Methods
Plasmids
GFP-MSH6 was a kind gift from A. Yasui and was described
previously [19]. Site-directed mutagenesis was utilized to create
the GFP-MSH6 mutations described. The GFP-MSH6 trunca-
tions were created by PCR amplification of amino acid residues,
101-1360, 211-1360 or 400–1360 of MSH6 by primers containing
XhoI and NotI restriction sites. The PCR products were then
digested and ligated into the modified pEGFP-C1 vector provided
by Yasui [19]. GFP-MSH6 and GFP-MSH6 D1–399 functionality
was determined by interaction with MSH2 (Figure S1). Addition-
ally, a wild-type MSH6 and MSH6 D NLS 2/3 with a FLAG
epitope (DYKDDDDK) in place of the GFP on the N-terminus
were created by PCR amplification. All clones were sequence
verified.
Cytoplasmic pyruvate kinase (p3PK) was a kind gift of J.
Frangioni and was previously described [26]. The pyruvate kinase
(PK) cassette was removed from the p3PK vector by digestion with
HindIII and BamHI, and ligated into pEGFP-N2. The frameshift
between the PK and the GFP was corrected by site-directed
mutagenesis, creating PK-GFP. Amino acids 241–315 of MSH6
were PCR amplified with primers containing NheI or BamHI. The
PCR product was digested and ligated into the NheI and BglII sites
of PK-GFP, creating NLS1,2,&3 PK-GFP. Site-directed muta-
genesis was used to remove individual NLSs, creating the NLS
variants used. All clones were sequence verified.
Colorectal cancer cell line DLD-1, deficient in msh6, and its
complemented, msh6 proficient counterpart, DLD-1 + chr.2 have
been extensively described [23,25] These cells were cultured under
standard culture conditions, using DMEM-F12 media (Gibco)
with 10% FBS. All cell lines were maintained at 37uCi na5 %
CO2 atmosphere. Cells were transiently transfected using
Lipofectamine 2000 (Invitrogen).
Immunoprecipitation and western blotting
Whole cell lysates were prepared by resuspending cell pellets in
NP40 lysis buffer, then sonicated to lyse cells. 500 mg of the lysate
was added to Dynabeads Protein G (Dynal, Invitrogen) pre-bound
with either anti-GFP antibody (abcam ab290). Anti-GFP beads
were incubated for 40 minutes at room temperature, then washed
and eluted according manufacturer’s protocol.
Eluted complexes were analyzed by SDS-Page. The presence of
protein was detected by 1 mg/mL anti-MSH2 (BD Biosciences
556349) and 1 mg/mL anti-MSH6 (BD Biosciences 610918)
against either mismatch repair protein.
Immunofluorescence
Cells were grown on poly-lysine coated dishes (MatTek Corp)
and fixed with a 10% neutral buffered formalin solution (Thermo
Scientific). After incubation in blocking solution, slides were
incubated with 2 mg/mL anti-MSH2, (Santa Cruz sc-494) or
4 mg/mL anti-FLAG M2, (Sigma F1804). Fluorescently tagged
secondary antibodies were used to visualize the protein and its
location. Anti-MSH2 antibody was recognized by an Alexa Fluor
546 goat anti-rabbit antibody (1:2500, Invitrogen). Anti-FLAG
antibody was recognized by an Alexa Fluor 488 goat anti-mouse
antibody (1:2500, Invitrogen) As controls, secondary antibody
alone or cells lacking the epitope for the primary antibody were
used.
Widefield Microscopy
Cultured cells were fixed and labeled as described. Cells were
then imaged with a 63x 1.4NA oil immersion objective on a Zeiss
AxioObserver widefield microscope (Carl Zeiss MicroImaging,
Thornwood, NY) equipped with a Hamamatsu Orca C4742-80-
12AG monochromatic digital camera (Hamamatsu, Bridgewater,
NJ) and an X-Cite metal halide fluorescent light source with the
aperture fully open (Exfo, Mississauga, Ontario). Hoechst stained
nuclei were visualized using a UV filter cube (DAPI-1160A,
Semrock, Rochester, NY) while GFP-MSH6 was visualized using
a GFP filter cube (Filter Set 13, Carl Zeiss MicroImaging,
Thornwood, NY). Images were acquired sequentially for each
channel using the Volocity Acquisition module (Perkin-Elmer,
Waltham, MA). Exposure time, gain, and offset were held constant
for all image acquisition.
Confocal microscopy
Fixed and labeled cells were also imaged using a Zeiss LSM 710
single-photon confocal microscope equipped with the quasar 34-
channel spectral detector (Carl Zeiss MicroImaging, Thornwood,
NY). 2-D images were acquired using a 63x 1.4NA oil-immersion
objective. For GFP imaging, the 488 nm laser line with a 488 long
pass dichroic with an emission range of 492–630 nm was used.
Hoechst staining could not be visualized on this microscope;
therefore a matching DIC image was acquired simultaneously to
confirm the position of the nucleus and to select the best focal
plane for nuclear imaging. Images were acquired with a pinhole of
1.36 airy unit (AU), a zoom of 1.0, using the 63x, 1.4 NA objective.
This resulted in images with individual pixel diameters of 0.09 mm,
which is necessary to satisfy the Nyquist sampling requirement for
this configuration. Laser power was set at 6% with a constant gain
setting of 780, for all quantification acquisitions. Gain setting was
determined by examining transiently transfected cells and creating
threshold ranges that grouped cells with similar intensity. Two of
these groupings, medium (gain 780) and low (gain 1080), best
recapitulate the nuclear localization of endogenous MSH6 without
aggregation of the GFP protein. The medium threshold was used
to obtain high resolution images for these studies, and only cells
showing under-saturation with these conditions were imaged and
quantified as described below. These same conditions were utilized
for quantifying immunofluorescent staining of endogenous MSH6
and FLAG-tagged constructs.
For GFP and Alexa 546 co-localization imaging, a multi-track
configuration was used to ensure no excitation cross-talk or
emission bleed-through between channels. The 488 nm laser line
was used at 6% of maximum intensity and the 543 nm laser line
with an emission range of 547–703 nm was used at 30% of
maximum intensity. Images were acquired with a pinhole of 1 airy
unit (AU), a zoom of 1.5, using the 63x, 1.4 NA objective. This
resulted in images with individual pixel diameters of 0.09 mm,
which is necessary to satisfy the Nyquist sampling requirement for
this configuration. Zen 2009 software was used for all image
acquisition.
Fluorescence Intensity Analysis
The intensity of the fusion protein fluorescent signal in the
nucleus and cytoplasm was compared quantitatively with acqui-
sition settings described above. Images were then analyzed using
the Volocity Quantitation module (Perkin-Elmer, Waltham, MA).
The fluorescent signal from the nuclei of labeled cells was selected
by drawing a region of interest (ROI) around each nucleus. A
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of the nucleus. The summed signal intensity from all the pixels in
the ROI (IROI) was then normalized by the number of pixels in the
ROI (NROI) and the background intensity of the image using the
following formula: Fobj=I ROI –N ROI*( I bkgd/Nbkgd). Background
was determined by drawing an ROI in an empty region of the
image and determining the summed signal normalized to the
number of pixels (average intensity)[46]. The fluorescent signal of
the cytoplasm was determined by drawing an ROI around the
entire cell and following the same procedure as described above to
determine the fluorescent signal normalized to background. The
contributions of the nucleus were then subtracted from this value
to give the fluorescent intensity of the cytoplasm alone. This
normalized intensity analysis was used to compare the distribution
of GFP-fusion proteins within the nucleus and cytoplasm of
individual cells. Forty to sixty cells were analyzed in this manner
for each mutant.
Accumulation of free GFP in the nucleus of DLD-1 cells was
measured as a control, and a homogeneous fluorescent signal was
noted in both nuclear and cytoplasmic compartment (N/
C=1.160.06). All N/C ratios were normalized to the free GFP
measurement.
Computational Cell Model
The computational cell model was constructed using the Virtual
Cell modeler from the National Resource for Cell Analysis and
Modeling (http://www.nrcam.uchc.edu/index.html)[47,48]. In
our model, the reactions are solved numerically with mass-action
kinetics[47]. Twelve species are included in the full model
(MSH6_cyto, MSH6_nuc, the binder to NLS1 (bNLS1), the
binder to NLS2 (bNLS2), the binder to NLS3 (bNLS3, MSH6/
bNLS1, MSH6/bNLS2, MSH6/bNLS3, MSH6/bNLS1/bNLS2,
MSH6/bNLS1/bNLS3, MSH6/bNLS2/bNLS3, MSH6/bNLS1/
bNLS2/bNLS3), with intermediate models consisting of only the
relevant species. On the time-scales considered here, only two
parameters were found to affectthe results,not surprisingly: the ratio
of the equilibrium constants for dissociation/formation in the
nucleus to the cytoplasm, and the concentrations of the species. So
the kinetic parameters were fixed save for the dissociation constants
within the nucleus. These concentrations and equilibrium constants
were varied logarithmically over three orders of magnitude from
1 mM and 1 mM/s, respectively. Final parameters were extracted
based on comparison to the experimental data on the import of
cyptoplasmic protein: the nuclear/cytoplasmic ratio was matched
under the assumption that the complexes are uncommon (,10% of
the MSH6 is in complex). The equilibrium constants were then
converted into free energies using dG=-RTlnK.
Supporting Information
Figure S1 Western blot of MSH2 and MSH6 immuno-
precipitated from transiently transfected msh6-deficient
DLD-1 cells. Both GFP-MSH6 and GFP-MSH6 D1-399 co-
precipitate MSH2 from cell lysates, demonstrating that there is no
defect in heterodimerization.
(TIF)
Figure S2 Immunofluorescence of endogenous MSH2
(Alexa-488, green) and MSH6 (Alexa-647, red) in non-
carcinogenic HEK293 cells. Scale bar is 10 mm.
(TIF)
Figure S3 Localization of MSH6 tagged with the much
smaller FLAG tag, as a control that measured effects are
not artifacts of tagging with GFP. Localization of A. wt
MSH6 and B. delta NLS2/3 MSH6 are shown. Nuclear/
cytoplasmic ratios for each measured construct are shown in C.
(TIF)
Figure S4 Western blot of MSH2 and MSH6 protein
levels in msh6-deficient DLD-1 cells compared to levels
found in non-carcinogenic HEK293 cells. Whole cell,
cytoplasmic and nuclear extracts were probed. Actin was used as
a loading control.
(TIF)
Figure S5 Localization of MSH6 and MSH2 in cells
lacking endogenous MSH3 and MSH6. A: Localization of
endogenous MSH2 in cells lacking MSH3 and MSH6. B:
Localization of GFP-MSH6-delta NLS2/3 and endogenous
MSH2 in these cells.
(TIF)
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